UniProt ID | DBF4A_HUMAN | |
---|---|---|
UniProt AC | Q9UBU7 | |
Protein Name | Protein DBF4 homolog A | |
Gene Name | DBF4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 674 | |
Subcellular Localization | Nucleus . | |
Protein Description | Regulatory subunit for CDC7 which activates its kinase activity thereby playing a central role in DNA replication and cell proliferation. Required for progression of S phase. The complex CDC7-DBF4A selectively phosphorylates MCM2 subunit at 'Ser-40' and 'Ser-53' and then is involved in regulating the initiation of DNA replication during cell cycle.. | |
Protein Sequence | MNSGAMRIHSKGHFQGGIQVKNEKNRPSLKSLKTDNRPEKSKCKPLWGKVFYLDLPSVTISEKLQKDIKDLGGRVEEFLSKDISYLISNKKEAKFAQTLGRISPVPSPESAYTAETTSPHPSHDGSSFKSPDTVCLSRGKLLVEKAIKDHDFIPSNSILSNALSWGVKILHIDDIRYYIEQKKKELYLLKKSSTSVRDGGKRVGSGAQKTRTGRLKKPFVKVEDMSQLYRPFYLQLTNMPFINYSIQKPCSPFDVDKPSSMQKQTQVKLRIQTDGDKYGGTSIQLQLKEKKKKGYCECCLQKYEDLETHLLSEQHRNFAQSNQYQVVDDIVSKLVFDFVEYEKDTPKKKRIKYSVGSLSPVSASVLKKTEQKEKVELQHISQKDCQEDDTTVKEQNFLYKETQETEKKLLFISEPIPHPSNELRGLNEKMSNKCSMLSTAEDDIRQNFTQLPLHKNKQECILDISEHTLSENDLEELRVDHYKCNIQASVHVSDFSTDNSGSQPKQKSDTVLFPAKDLKEKDLHSIFTHDSGLITINSSQEHLTVQAKAPFHTPPEEPNECDFKNMDSLPSGKIHRKVKIILGRNRKENLEPNAEFDKRTEFITQEENRICSSPVQSLLDLFQTSEEKSEFLGFTSYTEKSGICNVLDIWEEENSDNLLTAFFSSPSTSTFTGF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
10 | Phosphorylation | SGAMRIHSKGHFQGG CCCEEEECCCCCCCC | 37.65 | 24719451 | |
21 | Sumoylation | FQGGIQVKNEKNRPS CCCCEEECCCCCCCC | 42.91 | - | |
21 | Sumoylation | FQGGIQVKNEKNRPS CCCCEEECCCCCCCC | 42.91 | - | |
28 | Phosphorylation | KNEKNRPSLKSLKTD CCCCCCCCHHHCCCC | 45.23 | 29978859 | |
30 | Acetylation | EKNRPSLKSLKTDNR CCCCCCHHHCCCCCC | 59.07 | 25953088 | |
34 | Phosphorylation | PSLKSLKTDNRPEKS CCHHHCCCCCCCCCC | 43.74 | 22210691 | |
52 | Phosphorylation | PLWGKVFYLDLPSVT CCCCEEEEEECCCCC | 11.42 | 29083192 | |
57 | Phosphorylation | VFYLDLPSVTISEKL EEEEECCCCCHHHHH | 38.91 | 20873877 | |
59 | Phosphorylation | YLDLPSVTISEKLQK EEECCCCCHHHHHHH | 24.11 | 20873877 | |
61 | Phosphorylation | DLPSVTISEKLQKDI ECCCCCHHHHHHHHH | 21.22 | 29083192 | |
81 | Ubiquitination | RVEEFLSKDISYLIS HHHHHHCCCHHHHHC | 62.32 | - | |
84 | Phosphorylation | EFLSKDISYLISNKK HHHCCCHHHHHCCCH | 24.82 | 27135362 | |
88 | Phosphorylation | KDISYLISNKKEAKF CCHHHHHCCCHHHHH | 39.75 | 27135362 | |
98 | Phosphorylation | KEAKFAQTLGRISPV HHHHHHHHHCCCCCC | 27.96 | 23186163 | |
103 | Phosphorylation | AQTLGRISPVPSPES HHHHCCCCCCCCHHH | 20.63 | 25849741 | |
107 | Phosphorylation | GRISPVPSPESAYTA CCCCCCCCHHHCCCC | 41.35 | 20873877 | |
110 | Phosphorylation | SPVPSPESAYTAETT CCCCCHHHCCCCCCC | 29.93 | 20873877 | |
112 | Phosphorylation | VPSPESAYTAETTSP CCCHHHCCCCCCCCC | 18.76 | 20873877 | |
113 | Phosphorylation | PSPESAYTAETTSPH CCHHHCCCCCCCCCC | 20.10 | 20873877 | |
116 | Phosphorylation | ESAYTAETTSPHPSH HHCCCCCCCCCCCCC | 30.06 | 20873877 | |
117 | Phosphorylation | SAYTAETTSPHPSHD HCCCCCCCCCCCCCC | 31.59 | 20873877 | |
118 | Phosphorylation | AYTAETTSPHPSHDG CCCCCCCCCCCCCCC | 28.73 | 20873877 | |
122 | Phosphorylation | ETTSPHPSHDGSSFK CCCCCCCCCCCCCCC | 31.04 | 20873877 | |
126 | Phosphorylation | PHPSHDGSSFKSPDT CCCCCCCCCCCCCCE | 38.36 | 20873877 | |
127 | Phosphorylation | HPSHDGSSFKSPDTV CCCCCCCCCCCCCEE | 42.07 | 20873877 | |
130 | Phosphorylation | HDGSSFKSPDTVCLS CCCCCCCCCCEEEEC | 26.46 | 25159151 | |
140 | Ubiquitination | TVCLSRGKLLVEKAI EEEECCCCEEHHHHH | 37.22 | - | |
177 | Phosphorylation | LHIDDIRYYIEQKKK EEHHHHHHHHHHHHC | 14.77 | - | |
187 | Phosphorylation | EQKKKELYLLKKSST HHHHCEEEEEECCCC | 15.87 | 30108239 | |
194 | Phosphorylation | YLLKKSSTSVRDGGK EEEECCCCCCEECCE | 38.03 | 22817900 | |
195 | Phosphorylation | LLKKSSTSVRDGGKR EEECCCCCCEECCEE | 19.66 | 22817900 | |
201 | Ubiquitination | TSVRDGGKRVGSGAQ CCCEECCEECCCCCC | 49.82 | - | |
205 | Phosphorylation | DGGKRVGSGAQKTRT ECCEECCCCCCCCCC | 28.26 | 29496963 | |
210 | O-linked_Glycosylation | VGSGAQKTRTGRLKK CCCCCCCCCCCCCCC | 22.76 | 30379171 | |
212 | O-linked_Glycosylation | SGAQKTRTGRLKKPF CCCCCCCCCCCCCCE | 31.70 | 30379171 | |
259 | Phosphorylation | PFDVDKPSSMQKQTQ CCCCCCCCHHCCCCE | 44.15 | 25627689 | |
260 | Phosphorylation | FDVDKPSSMQKQTQV CCCCCCCHHCCCCEE | 33.49 | 25159151 | |
273 | Phosphorylation | QVKLRIQTDGDKYGG EEEEEEECCCCCCCC | 39.31 | 25159151 | |
278 | Phosphorylation | IQTDGDKYGGTSIQL EECCCCCCCCEEEEE | 26.06 | 20873877 | |
281 | Phosphorylation | DGDKYGGTSIQLQLK CCCCCCCEEEEEEEH | 20.49 | 20873877 | |
282 | Phosphorylation | GDKYGGTSIQLQLKE CCCCCCEEEEEEEHH | 16.18 | 20873877 | |
303 | Phosphorylation | CECCLQKYEDLETHL HHHHHHHHHHHHHHH | 11.17 | - | |
312 | Phosphorylation | DLETHLLSEQHRNFA HHHHHHHCHHHHHHH | 41.38 | 25849741 | |
341 | Phosphorylation | LVFDFVEYEKDTPKK HHHHHHHCCCCCCCC | 23.99 | 28450419 | |
345 | Phosphorylation | FVEYEKDTPKKKRIK HHHCCCCCCCCCCEE | 48.34 | 30266825 | |
353 | Phosphorylation | PKKKRIKYSVGSLSP CCCCCEEEECCCCCC | 13.25 | 28176443 | |
354 | Phosphorylation | KKKRIKYSVGSLSPV CCCCEEEECCCCCCC | 18.26 | 25159151 | |
357 | Phosphorylation | RIKYSVGSLSPVSAS CEEEECCCCCCCCHH | 24.42 | 30266825 | |
359 | Phosphorylation | KYSVGSLSPVSASVL EEECCCCCCCCHHHH | 25.59 | 29255136 | |
362 | Phosphorylation | VGSLSPVSASVLKKT CCCCCCCCHHHHHHH | 20.43 | 30266825 | |
364 | Phosphorylation | SLSPVSASVLKKTEQ CCCCCCHHHHHHHHC | 22.07 | 30266825 | |
381 | Phosphorylation | KVELQHISQKDCQED HEEEEECCHHHCCCC | 29.11 | 23401153 | |
393 | Ubiquitination | QEDDTTVKEQNFLYK CCCCCCHHHHCCEEC | 52.03 | - | |
408 | Sumoylation | ETQETEKKLLFISEP CCHHHHHEEEEEECC | 44.16 | - | |
408 | Sumoylation | ETQETEKKLLFISEP CCHHHHHEEEEEECC | 44.16 | - | |
413 | Phosphorylation | EKKLLFISEPIPHPS HHEEEEEECCCCCCC | 29.95 | 29255136 | |
420 | Phosphorylation | SEPIPHPSNELRGLN ECCCCCCCHHHHCHH | 39.64 | 25159151 | |
429 | Ubiquitination | ELRGLNEKMSNKCSM HHHCHHHHHCCHHHH | 46.70 | - | |
431 | Phosphorylation | RGLNEKMSNKCSMLS HCHHHHHCCHHHHHH | 44.18 | 27732954 | |
435 | Phosphorylation | EKMSNKCSMLSTAED HHHCCHHHHHHCCHH | 25.11 | 21815630 | |
438 | Phosphorylation | SNKCSMLSTAEDDIR CCHHHHHHCCHHHHH | 19.55 | 28165663 | |
439 | Phosphorylation | NKCSMLSTAEDDIRQ CHHHHHHCCHHHHHH | 30.06 | 21815630 | |
449 | Phosphorylation | DDIRQNFTQLPLHKN HHHHHHCCCCCCCCC | 36.42 | 22123827 | |
455 | Ubiquitination | FTQLPLHKNKQECIL CCCCCCCCCHHEEEE | 73.79 | - | |
465 | Phosphorylation | QECILDISEHTLSEN HEEEEECCCCCCCHH | 24.00 | 27422710 | |
468 | Phosphorylation | ILDISEHTLSENDLE EEECCCCCCCHHHHH | 28.11 | 20873877 | |
470 | Phosphorylation | DISEHTLSENDLEEL ECCCCCCCHHHHHHH | 35.19 | 27422710 | |
502 | Phosphorylation | FSTDNSGSQPKQKSD CCCCCCCCCCCCCCC | 43.03 | 22123827 | |
508 | Phosphorylation | GSQPKQKSDTVLFPA CCCCCCCCCEEEEEH | 35.70 | 30266825 | |
510 | Phosphorylation | QPKQKSDTVLFPAKD CCCCCCCEEEEEHHH | 26.63 | 30266825 | |
535 | Phosphorylation | THDSGLITINSSQEH ECCCCEEEECCCCCE | 21.10 | 17525332 | |
538 | Phosphorylation | SGLITINSSQEHLTV CCEEEECCCCCEEEE | 29.55 | 29523821 | |
539 | Phosphorylation | GLITINSSQEHLTVQ CEEEECCCCCEEEEE | 34.79 | 17525332 | |
544 | Phosphorylation | NSSQEHLTVQAKAPF CCCCCEEEEEEECCC | 16.69 | 29523821 | |
553 | Phosphorylation | QAKAPFHTPPEEPNE EEECCCCCCCCCCCC | 40.70 | 23401153 | |
568 | Phosphorylation | CDFKNMDSLPSGKIH CCCCCCCCCCCCCHH | 31.26 | 25159151 | |
571 | Phosphorylation | KNMDSLPSGKIHRKV CCCCCCCCCCHHCEE | 58.99 | 29255136 | |
573 | Acetylation | MDSLPSGKIHRKVKI CCCCCCCCHHCEEEE | 39.41 | 25953088 | |
579 | Sumoylation | GKIHRKVKIILGRNR CCHHCEEEEEECCCH | 27.37 | - | |
579 | Sumoylation | GKIHRKVKIILGRNR CCHHCEEEEEECCCH | 27.37 | - | |
612 | Phosphorylation | QEENRICSSPVQSLL HHHHCCCCCHHHHHH | 34.99 | 20873877 | |
613 | Phosphorylation | EENRICSSPVQSLLD HHHCCCCCHHHHHHH | 25.36 | 20873877 | |
617 | Phosphorylation | ICSSPVQSLLDLFQT CCCCHHHHHHHHHCC | 31.00 | 27732954 | |
624 | Phosphorylation | SLLDLFQTSEEKSEF HHHHHHCCCHHHHHH | 30.67 | 30177828 | |
625 | Phosphorylation | LLDLFQTSEEKSEFL HHHHHCCCHHHHHHC | 32.73 | 20873877 | |
629 | Phosphorylation | FQTSEEKSEFLGFTS HCCCHHHHHHCCCCC | 36.54 | 22777824 | |
635 | Phosphorylation | KSEFLGFTSYTEKSG HHHHCCCCCCCCCCC | 21.01 | 28450419 | |
636 | Phosphorylation | SEFLGFTSYTEKSGI HHHCCCCCCCCCCCC | 28.00 | 21815630 | |
637 | Phosphorylation | EFLGFTSYTEKSGIC HHCCCCCCCCCCCCC | 18.83 | 28450419 | |
638 | Phosphorylation | FLGFTSYTEKSGICN HCCCCCCCCCCCCCE | 36.38 | 28450419 | |
664 | Phosphorylation | NLLTAFFSSPSTSTF CCCHHHHCCCCCCCC | 34.58 | - | |
665 | Phosphorylation | LLTAFFSSPSTSTFT CCHHHHCCCCCCCCC | 20.08 | - | |
667 | Phosphorylation | TAFFSSPSTSTFTGF HHHHCCCCCCCCCCC | 36.62 | 29997176 | |
669 | Phosphorylation | FFSSPSTSTFTGF-- HHCCCCCCCCCCC-- | 26.34 | 29997176 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
273 | T | Phosphorylation | Kinase | CDC7 | O00311 | PSP |
281 | T | Phosphorylation | Kinase | CDC7 | O00311 | PSP |
312 | S | Phosphorylation | Kinase | CDC7 | O00311 | PSP |
449 | T | Phosphorylation | Kinase | ATM | Q13315 | PSP |
449 | T | Phosphorylation | Kinase | ATR | Q13535 | PSP |
502 | S | Phosphorylation | Kinase | ATM | Q13315 | PSP |
502 | S | Phosphorylation | Kinase | ATR | Q13535 | PSP |
539 | S | Phosphorylation | Kinase | ATM | Q13315 | PSP |
539 | S | Phosphorylation | Kinase | ATR | Q13535 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DBF4A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DBF4A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
MCM2_HUMAN | MCM2 | physical | 12614612 | |
ORC1_HUMAN | ORC1 | physical | 12614612 | |
ORC2_HUMAN | ORC2 | physical | 12614612 | |
ORC5_HUMAN | ORC5 | physical | 12614612 | |
ORC6_HUMAN | ORC6 | physical | 12614612 | |
MCM3_HUMAN | MCM3 | physical | 12614612 | |
MCM4_HUMAN | MCM4 | physical | 12614612 | |
MCM7_HUMAN | MCM7 | physical | 12614612 | |
ORC4_HUMAN | ORC4 | physical | 12614612 | |
CDC7_HUMAN | CDC7 | physical | 10523313 | |
CDC7_HUMAN | CDC7 | physical | 10373557 | |
CDC7_HUMAN | CDC7 | physical | 16912045 | |
DBF4A_HUMAN | DBF4 | physical | 12968034 | |
DAXX_HUMAN | DAXX | physical | 12968034 | |
MCM2_HUMAN | MCM2 | physical | 10846177 | |
CDC7_HUMAN | CDC7 | physical | 10846177 | |
DBF4A_HUMAN | DBF4 | physical | 10846177 | |
MCM4_HUMAN | MCM4 | physical | 10846177 | |
MCM6_HUMAN | MCM6 | physical | 10846177 | |
MCM7_HUMAN | MCM7 | physical | 10846177 | |
RAD18_HUMAN | RAD18 | physical | 24240236 | |
HDGR2_HUMAN | HDGFRP2 | physical | 28514442 | |
CDC7_HUMAN | CDC7 | physical | 28514442 | |
NDK6_HUMAN | NME6 | physical | 28514442 | |
EF1A2_HUMAN | EEF1A2 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-359, AND MASSSPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-273; THR-345; SER-359;SER-381; SER-413 AND SER-508, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-359, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-354 AND SER-359, ANDMASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-359 AND SER-381, ANDMASS SPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-381; THR-535 ANDSER-539, AND MASS SPECTROMETRY. |